Alive (n = 121) | Deceased (n = 38) | P value | |
---|---|---|---|
Proportion of patients with poor prognosis score (%) | 0.34 | 0.74 | <0.0001 |
Mean age at breast cancer diagnosis (years) | 57.5 (±12.4) | 58.8 (±16.8) | 0.59 |
Mean tumor size (mm) | 21.3 (±11.5) | 25.6 (±12.6) | 0.05 |
Proportion of patients with tumor size <21 mm (%) | 0.65 | 0.47 | 0.06 |
Proportion of patients with positive lymph nodes (%) | 0.37 | 0.39 | 0.71 |
Proportion of patients with grade I (%) | 0.23 | 0.08 | 0.06a |
Proportion of patients with grade II (%) | 0.41 | 0.36 | |
Proportion of patients with grade III (%) | 0.36 | 0.56 | |
Proportion of patients with estrogen-receptor-positive tumors (%) | 0.83 | 0.79 | 0.61 |
Proportion of patients with progesterone-receptor-positive tumors (%) | 0.77 | 0.55 | 0.01 |
Proportion of patients receiving chemotherapy (%) | 0.18 | 0.21 | 0.69 |
Proportion of patients receiving endocrine therapy (%) | 0.76 | 0.58 | 0.03 |
Proportion of patients receiving radiotherapy (%) | 0.51 | 0.39 | 0.21 |